IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
Developing in-licensed therapies for a variety of indications in China.
Industry: Health Care
Latest Trade: $0.30 -0.02 (-6.6%)
First Day Return: -14.4%
Return from IPO: -98.0%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 10/01/2021 |
Offer Price | $16.00 |
Price Range $15.00 - $17.00 | |
Offer Shares (mm) | 20.3 |
Deal Size ($mm) | $325 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 10/31/2021 |
Offer Price | $16.00 |
Price Range $15.00 - $17.00 | |
Offer Shares (mm) | 20.3 |
Deal Size ($mm) | $325 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
Goldman Sachs |
Jefferies |
more |
Company Data | |
---|---|
Headquarters | Shanghai, China |
Founded | 2019 |
Employees | 87 |
Website www.lianbio.com |